Award

A Quantitative Epigenetic Test for Guiding Smoking Cessation Therapy

Description: Narrative: This project will demonstrate the clinical reliability of a new epigenetic test for smoking cessation treatment and advance it to FDA approval.
Funding type: research
Funder scheme: R44
Start date: 2016-09-15
End date: 2019-08-31
Investigator: ROBERT A PHILIBERT
Institution: BD HOLDING, INC.
Funded outputs count: 14
Funder award ID: R44CA213507
OpenAlex ID: G6423291161
2021 · Robert Philibert, Kelsey Dawes, et al. · Genes · 7
2020 · Allan M. Andersen, Man-Kit Lei, et al. · Journal of Psychosomatic Research · 12
2019 · Robert Philibert, Meeshanthini Dogan, et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 75
2018 · Robert Philibert, Meesha Dogan, et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 31
2018 · Allan M. Andersen, Philip T. Ryan, et al. · Journal of Insurance Medicine · 5
2017 · Robert Philibert, Stephen J. Glatt · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 3
Year
Topic